Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-31

Clinical Trial Update: Efficacy and Safety of Toluedesvenlafaxine Hydrochloride Extended-release Tablets in Somatic Symptoms of Depression [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of toludesvenlafaxine hydrochloride extended-release tablets in somatic symptoms of depression has been complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Toluedesvenlafaxine hydrochloride extended-release tablets (Toluedesvenlafaxine hydrochloride)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Somatic Symptom | Phase 4 | Status: COMPLETED